发明名称 |
Protein tyrosine kinase inhibitors |
摘要 |
The present invention relates to compounds of the Formula I, the pharmaceutically acceptable salts and stereoisomers thereof, which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions in mammals: wherein n is an integer, preferably n is 1; wherein R1 and R2 are independently selected from the group consisting of:
|
申请公布号 |
US7585866(B2) |
申请公布日期 |
2009.09.08 |
申请号 |
US20050522944 |
申请日期 |
2005.07.28 |
申请人 |
CRITICAL OUTCOME TECHNOLOGIES, INC. |
发明人 |
DANTER WAYNE R.;BROWN MARTYN;MA GEORGE;RUSU GHENADIE;ZHONG JIANHUA;LAZAROWYCH NATALIE;HOULDSWORTH STEPHEN |
分类号 |
C07D401/14;A61K31/506;A61P35/00 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|